Get 30% Off Your First Skin Rejuvenation Service As A New Client

Mounjaro - Medical Weight Injections

Mounjaro is a once-weekly injectable medication designed to help you achieve your weight loss goals with ease.

FDA Approved

Reduced Cravings

Improved Metabolic Health

Long-Term Weight Management

What is Mounjaro (tirzepatide)?

Mounjaro® (tirzepatide) is a GLP-1 and GIP receptor agonist designed to help manage type 2 diabetes by regulating blood sugar levels. While FDA-approved for diabetes, it is also prescribed off-label for weight management due to its appetite-suppressing and metabolic-enhancing properties.

How Mounjaro Supports Weight Management:

  • Improves your body’s ability to respond to sugars
  • Targets both GLP-1 and GIP receptors to optimize weight loss
  • Stimulates insulin production while lowering blood sugar levels

 

Although not FDA-approved for weight loss, healthcare providers may prescribe Mounjaro off-label based on individual health needs.

Learn more about real patient experiences at Coastal Wellness MD and explore clinical insights in the Tirzepatide vs. Placebo study by Lilly.

Most patients see an average weight loss of around 35 pounds

Quick & Hassle-Free Reservations

 Choose your preferred date and time in just a few clicks. Our user-friendly system makes it easy to reserve your spot—no phone calls, no waiting.

 Once you book, you’ll receive immediate confirmation and reminders, so you’re always in the loop about your upcoming appointment.

Whether it’s an urgent concern or a general wellness check, our experienced team is here to diagnose and treat you with compassion, efficiency, and comfort—right when you need it most.

FAQ's

Mounjaro is approved for diabetes but used off-label. It contains tirzepatide and offer up to 22% weight loss in trials.

Tirzepatide activates both GLP-1 and GIP hormones—helping suppress appetite, increase satiety, and improve insulin function even more powerfully than GLP-1s alone.

Patients often lose 20–22% of their body weight with lifestyle support

Yes. Side effects are similar to GLP-1s but may include more GI symptoms in early weeks.

Same as GLP-1: patients with thyroid cancer history, MEN2, severe GI disorders, or known allergies to tirzepatide.

Yes. We evaluate A1C, glucose, thyroid, kidney, and liver function before treatment.

These are weekly auto-injections. We walk you through step-by-step use.

Mostly GI-related: nausea, bloating, constipation. Rare but possible: gallbladder issues, pancreatitis, allergic reactions.

Connect With Our Team

Your wellness experience starts here. Submit your inquiry and we’ll take care of the rest.